Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development (including related party expenses of $0 and $1,612 for the three months ended March 31, 2022 and 2021, respectively	$ 31,678	$ 17,258
General and administrative	7,543	5,885
Total operating expenses	39,221	23,143
Loss from operations	(39,221)	(23,143)
Other income (expense), net:
Interest income	134	61
Grant income	160
Realized loss on marketable securities	(65)
Foreign currency transaction gains	6	1,862
Total other income (expense), net	235	1,923
Net loss	$ (38,986)	$ (21,220)
Net loss per share, basic and diluted	$ (0.68)	$ (0.41)
Weighted-average shares outstanding, basic and diluted	57,547,808	51,174,978